Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum
- PMID: 23236420
- PMCID: PMC3517603
- DOI: 10.1371/journal.pone.0051024
Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum
Abstract
The multiple endocrine neoplasia type 2A (MEN2A) is a monogenic disorder characterized by an autosomal dominant pattern of inheritance which is characterized by high risk of medullary thyroid carcinoma in all mutation carriers. Although this disorder is classified as a rare disease, the patients affected have a low life quality and a very expensive and continuous treatment. At present, MEN2A is diagnosed by gene sequencing after birth, thus trying to start an early treatment and by reduction of morbidity and mortality. We first evaluated the presence of MEN2A mutation (C634Y) in serum of 25 patients, previously diagnosed by sequencing in peripheral blood leucocytes, using HRM genotyping analysis. In a second step, we used a COLD-PCR approach followed by HRM genotyping analysis for non-invasive prenatal diagnosis of a pregnant woman carrying a fetus with a C634Y mutation. HRM analysis revealed differences in melting curve shapes that correlated with patients diagnosed for MEN2A by gene sequencing analysis with 100% accuracy. Moreover, the pregnant woman carrying the fetus with the C634Y mutation revealed a melting curve shape in agreement with the positive controls in the COLD-PCR study. The mutation was confirmed by sequencing of the COLD-PCR amplification product. In conclusion, we have established a HRM analysis in serum samples as a new primary diagnosis method suitable for the detection of C634Y mutations in MEN2A patients. Simultaneously, we have applied the increase of sensitivity of COLD-PCR assay approach combined with HRM analysis for the non-invasive prenatal diagnosis of C634Y fetal mutations using pregnant women serum.
Conflict of interest statement
Figures



Similar articles
-
RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.Clin Endocrinol (Oxf). 2007 Oct;67(4):570-6. doi: 10.1111/j.1365-2265.2007.02927.x. Epub 2007 Jun 15. Clin Endocrinol (Oxf). 2007. PMID: 17573899
-
[Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up].Zhonghua Nei Ke Za Zhi. 2007 Nov;46(11):914-8. Zhonghua Nei Ke Za Zhi. 2007. PMID: 18261274 Chinese.
-
[The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].Zhonghua Nei Ke Za Zhi. 2007 Jun;46(6):466-70. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17663821 Chinese.
-
Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.Eur J Endocrinol. 2008 Dec;159(6):767-71. doi: 10.1530/EJE-08-0476. Epub 2008 Sep 19. Eur J Endocrinol. 2008. PMID: 18805915 Review.
-
Diagnostic correlation between RET proto-oncogene mutation, imaging techniques, biochemical markers and morphological examination in MEN2A syndrome: case report and literature review.Rom J Morphol Embryol. 2014;55(2):389-400. Rom J Morphol Embryol. 2014. PMID: 24969991 Review.
Cited by
-
Application of coamplification at lower denaturation temperature-PCR sequencing for early detection of antiviral drug resistance mutations of hepatitis B virus.J Clin Microbiol. 2014 Sep;52(9):3209-15. doi: 10.1128/JCM.00343-14. Epub 2014 Jun 20. J Clin Microbiol. 2014. PMID: 24951803 Free PMC article.
-
Diagnosis and surgical treatment of multiple endocrine neoplasia type 2A.World J Surg Oncol. 2014 Jan 9;12:8. doi: 10.1186/1477-7819-12-8. World J Surg Oncol. 2014. PMID: 24400812 Free PMC article.
-
5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.Front Endocrinol (Lausanne). 2020 Sep 18;11:543246. doi: 10.3389/fendo.2020.543246. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33071967 Free PMC article. Review.
-
Thyroid nodules and cancer during pregnancy, post-partum and preconception planning: Addressing the uncertainties and challenges.Best Pract Res Clin Endocrinol Metab. 2020 Jul;34(4):101363. doi: 10.1016/j.beem.2019.101363. Epub 2019 Nov 22. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 31786102 Free PMC article. Review.
-
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335. Thyroid. 2015. PMID: 25810047 Free PMC article. Review.
References
-
- Moline J, Eng C (2011) Multiple endocrine neoplasia type 2: an overview. Genet Med 13: 755–764. - PubMed
-
- Akerstrom G, Stalberg P (2009) Surgical management of MEN-1 and -2: state of the art. Surg Clin N Am 89: 1047–1068. - PubMed
-
- Quayle FJ, Fialkowski EA, Benveniste R, Moley JF (2007) Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142: 800–805. - PubMed
-
- Raue F, Kraimps JL, Dralle H, Cougard P, Proye C, et al. (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Int Med 238: 369–373. - PubMed